Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Large envelope protein (Hepatitis B virus) | BDBM289769 (US10093673, Compound 1.1) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ... | US Patent US10093673 (2018) BindingDB Entry DOI: 10.7270/Q2WH2S21 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Large envelope protein (Hepatitis B virus) | BDBM289780 (US10093673, Compound 7.2) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 90 | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ... | US Patent US10093673 (2018) BindingDB Entry DOI: 10.7270/Q2WH2S21 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Large envelope protein (Hepatitis B virus) | BDBM289775 (US10093673, Compound 5.1) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6 | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ... | US Patent US10093673 (2018) BindingDB Entry DOI: 10.7270/Q2WH2S21 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Large envelope protein (Hepatitis B virus) | BDBM289779 (US10093673, Compound 7.1) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.800 | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ... | US Patent US10093673 (2018) BindingDB Entry DOI: 10.7270/Q2WH2S21 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Large envelope protein (Hepatitis B virus) | BDBM246810 (US10053461, 1 | US10093673, Compound rac-2 | trans...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 460 | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ... | US Patent US10093673 (2018) BindingDB Entry DOI: 10.7270/Q2WH2S21 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Large envelope protein (Hepatitis B virus) | BDBM246811 (US10053461, 2 | US10093673, Compound 1.2 | cis-10-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 13 | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ... | US Patent US10093673 (2018) BindingDB Entry DOI: 10.7270/Q2WH2S21 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Large envelope protein (Hepatitis B virus) | BDBM289777 (US10093673, Compound 6.1 | US10093673, Compound 6....) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ... | US Patent US10093673 (2018) BindingDB Entry DOI: 10.7270/Q2WH2S21 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Large envelope protein (Hepatitis B virus) | BDBM289781 (US10093673, Compound 8.1) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ... | US Patent US10093673 (2018) BindingDB Entry DOI: 10.7270/Q2WH2S21 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Large envelope protein (Hepatitis B virus) | BDBM289782 (US10093673, Compound 9.1 | US10093673, Compound 9....) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9 | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ... | US Patent US10093673 (2018) BindingDB Entry DOI: 10.7270/Q2WH2S21 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Large envelope protein (Hepatitis B virus) | BDBM289782 (US10093673, Compound 9.1 | US10093673, Compound 9....) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 303 | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ... | US Patent US10093673 (2018) BindingDB Entry DOI: 10.7270/Q2WH2S21 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Large envelope protein (Hepatitis B virus) | BDBM289774 (US10093673, Compound 4.1) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.300 | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ... | US Patent US10093673 (2018) BindingDB Entry DOI: 10.7270/Q2WH2S21 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Large envelope protein (Hepatitis B virus) | BDBM289776 (US10093673, Compound 5.2) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ... | US Patent US10093673 (2018) BindingDB Entry DOI: 10.7270/Q2WH2S21 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Large envelope protein (Hepatitis B virus) | BDBM289777 (US10093673, Compound 6.1 | US10093673, Compound 6....) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9 | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ... | US Patent US10093673 (2018) BindingDB Entry DOI: 10.7270/Q2WH2S21 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Large envelope protein (Hepatitis B virus) | BDBM289773 (US10093673, Compound 3.2) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 740 | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ... | US Patent US10093673 (2018) BindingDB Entry DOI: 10.7270/Q2WH2S21 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Large envelope protein (Hepatitis B virus) | BDBM289772 (US10093673, Compound 3.1) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.300 | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ... | US Patent US10093673 (2018) BindingDB Entry DOI: 10.7270/Q2WH2S21 | |||||||||||
More data for this Ligand-Target Pair |